These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31655510)

  • 21. Cystic fibrosis newborn screening: Five-year experience from a tertiary care center.
    Nayir Buyuksahin H; Emiralioglu N; Ozsezen B; Ademhan Tural D; Sunman B; Guzelkas I; Tezel B; Dayangaç Erden D; Yalçın E; Dogru D; Ozcelik U; Kiper N
    Pediatr Pulmonol; 2022 Feb; 57(2):403-410. PubMed ID: 34842364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective and parallel assessments of cystic fibrosis newborn screening protocols in the Czech Republic: IRT/DNA/IRT versus IRT/PAP and IRT/PAP/DNA.
    Krulišová V; Balaščaková M; Skalická V; Piskáčková T; Holubová A; Paděrová J; Křenková P; Dvořáková L; Zemková D; Kračmar P; Chovancová B; Vávrová V; Stambergová A; Votava F; Macek M
    Eur J Pediatr; 2012 Aug; 171(8):1223-9. PubMed ID: 22581207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols.
    Gregg RG; Wilfond BS; Farrell PM; Laxova A; Hassemer D; Mischler EH
    Am J Hum Genet; 1993 Mar; 52(3):616-26. PubMed ID: 7680526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test.
    Rock MJ; Mischler EH; Farrell PM; Bruns WT; Hassemer DJ; Laessig RH
    Pediatr Pulmonol; 1989; 6(1):42-8. PubMed ID: 2704582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium.
    Schmidt M; Werbrouck A; Verhaeghe N; De Wachter E; Simoens S; Annemans L; Putman K
    Acta Clin Belg; 2020 Jun; 75(3):212-220. PubMed ID: 31007159
    [No Abstract]   [Full Text] [Related]  

  • 26. Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.
    Bozdogan ST; Mujde C; Boga I; Sonmezler O; Hanta A; Rencuzogullari C; Ozcan D; Altintas DU; Bisgin A
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newborn screening for cystic fibrosis in Switzerland--consequences after analysis of a 4 months pilot study.
    Torresani T; Fingerhut R; Rueegg CS; Gallati S; Kuehni CE; Baumgartner MR; Barben J;
    J Cyst Fibros; 2013 Dec; 12(6):667-74. PubMed ID: 23712087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study.
    Vernooij-van Langen AM; Loeber JG; Elvers B; Triepels RH; Gille JJ; Van der Ploeg CP; Reijntjens S; Dompeling E; Dankert-Roelse JE;
    Thorax; 2012 Apr; 67(4):289-95. PubMed ID: 22271776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers.
    Castellani C; Picci L; Scarpa M; Dechecchi MC; Zanolla L; Assael BM; Zacchello F
    Am J Med Genet A; 2005 Jun; 135(2):142-4. PubMed ID: 15832355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal cystic fibrosis screening: Analysis and differences in immunoreactive trypsin levels in newborns with a positive screen.
    Arrudi-Moreno M; García-Romero R; Samper-Villagrasa P; Sánchez-Malo MJ; Martin-de-Vicente C
    An Pediatr (Engl Ed); 2021 Jul; 95(1):11-17. PubMed ID: 34140271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAP assays in newborn screening for cystic fibrosis: a population-based cost-effectiveness study.
    Seror V; Cao C; Roussey M; Giorgi R
    J Med Screen; 2016 Jun; 23(2):62-9. PubMed ID: 26304152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two years of newborn screening for cystic fibrosis in Turkey: Çukurova experience.
    Şaşihüseyinoğlu AŞ; Altıntaş DU; Bişgin A; Doğruel D; Yılmaz M; Serbes M
    Turk J Pediatr; 2019; 61(4):505-512. PubMed ID: 31990467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons learned from 20 years of newborn screening for cystic fibrosis.
    Massie RJ; Curnow L; Glazner J; Armstrong DS; Francis I
    Med J Aust; 2012 Jan; 196(1):67-70. PubMed ID: 22256939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.
    Rock MJ; Mischler EH; Farrell PM; Wei LJ; Bruns WT; Hassemer DJ; Laessig RH
    Pediatrics; 1990 Jun; 85(6):1001-7. PubMed ID: 2187173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False negatives in the newborn screening for cystic fibrosis in Western Andalusia: Results from a 10-year experience.
    Escudero-Ávila R; Delgado-Pecellín C; Moreno-Valera MJ; Carrasco-Hernández L; Quintana-Gallego ME; Delgado-Pecellín I
    Pediatr Pulmonol; 2023 Sep; 58(9):2464-2468. PubMed ID: 36196044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thirty-years of screening for cystic fibrosis in East Anglia.
    Calvin J; Hogg SL; McShane D; McAuley SA; Iles R; Ross-Russell R; MacLean FM; Heeley ME; Heeley AF;
    Arch Dis Child; 2012 Dec; 97(12):1043-7. PubMed ID: 23076339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.